Podcast Pearls
Radiopharmaceuticals in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Download this Podcast Pearls slideset based on the content from a CCO podcast covering recent new developments in the treatment of patients with metastatic castration-resistant prostate cancer.
Chris Parker, MD
Bertrand Tombal, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 373 KB
Released: July 20, 2021

Acknowledgements

Supported by an educational grant from
Bayer HealthCare

Related Content

Downloadable clinical resource with practical guidance on how to talk with your transgender patients about gender identity, including related terminology, from Clinical Care Options (CCO)

Nelson F. Sanchez, MD
Program Director
Released: June 30, 2022

Commentary from Nelson F. Sanchez, MD, on caring for transgender individuals, from the healthcare disparities they face to how healthcare professionals can improve their care, from Clinical Care Options (CCO)

Nelson F. Sanchez, MD
Program Director
Released: June 28, 2022

Clinical Care Options (CCO): Dr Heather Cheng answers audience questions from a live symposium on current and expanding role of PARP inhibitors in prostate cancer care

Heather H. Cheng, MD, PhD Released: April 26, 2022

Clinical Care Options (CCO): Expert analysis from Drs. Daniel Petrylak and Toni Choueiri on key data in genitourinary cancers from ASCO GU 2022

Toni K. Choueiri, MD Daniel P. Petrylak, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 18, 2022 Expired: April 17, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings